SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IGEN International -- Ignore unavailable to you. Want to Upgrade?

To: John Zwiener who wrote (424)9/3/1998 8:29:00 PM
From: John Zwiener  Read Replies (1) | Respond to of 1025
 
Rumors of short covering, new buying, and possible big agreements floating around. Inquiries seem to support negotiations are jumping forward in a rapid fashion. Possible rapid reversal may be brewing.
I know Igen is underpriced, it is not your typical company with earning years out in the future. I wait and will join in the buying.



To: John Zwiener who wrote (424)9/4/1998 12:46:00 AM
From: James Perry  Read Replies (1) | Respond to of 1025
 
Oh hell, I can see it now. Igen is developing her instrument. Roche is developing a different instrument, both high throughput. And I will bet all the labs and hospitals will like the Igen instrument the best. We will never get them out of court then!!!


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News